I do agree with you that if they can not do it on their own, they will find a partner to bring the drug to fruition. Like I said before, cancer drugs are big business. I also like your point about dilution, it is something those who are wanting to invest have to consider and to be quite honest did not even cross my mind when doing my brief write-up. Another possible outcome could be a buyout from one of the larger players in the drug biz, which would probably not be that bad for investors either.
"The only thing that interferes with my learning is my education." - Albert Einstein